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Abstract
Background: With current treatments, approximately 75% of children diagnosed with cancer can
expect to achieve disease-free survival. However, treatments are complex and aggressive,
potentially compromising QOL for children and their parents. Although previous work has shown
increased anxiety and depression among parents after diagnosis, the recent development of
standardised measures of QOL enables us to look more directly at the impact of diagnosis on
mothers' and children's QOL. The aims of this study are to i) describe QOL for children and their
mothers after diagnosis by comparing their scores with population norms, ii) explore the
relationship between mothers' worries about the illness and their QOL, and iii) determine the
relationship between mothers ratings of their own QOL and their child.
Method: A total of 87 families took part, constituting 60% of those eligible. The children included
58 males and 29 females aged between 2 years 6 months to 16 years 3 months (mean = 7 years,
median = 5 years 8 months). Diagnoses were acute lymphoblastic leukaemia (ALL, n = 57), brain
tumours (n = 11), bone tumours (n = 17) and 2 rare cancers. Mothers completed questionnaires
about their own and the child's QOL.
Results:  Mothers' reported their own and the child's QOL to be significantly lower than
population norms. There were significant correlations between mothers' worries and their own
and their ratings of the child's QOL and mothers' ratings of their own QOL correlated with their
ratings of the child's QOL.
Conclusion: Both children and their mothers experience significantly compromised QOL in the
months following diagnosis. Mothers who rated their own QOL to be poor also rate their child's
QOL to be low. These results suggest caution is required where mothers rate their child's QOL.
Efforts must continue to be made to improve QOL of children especially in the period immediately
following diagnosis.
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Background
Survival in childhood cancer has improved significantly
in recent years [1,2]. This has been attributed to the organ-
isation of care in key centres, and development of
national and international clinical trials which facilitate
more rapid knowledge and refinements of new protocols.
Depending on the specific cancer, children are treated
with a combination of radiotherapy, chemotherapy and
surgery. Duration of chemotherapy also varies but can be
up to 3 years for boys treated for the most common can-
cer, acute lymphoblastic leukaemia (ALL).
Despite the improved survival statistics, cancer remains a
potentially life-threatening condition, and as such poses a
major challenge to both child and family. During the
course of treatment, most children experience unpleasant
physical side-effects. Behavioural and emotional prob-
lems have also been identified. In the longer term, there is
a considerable risk of late effects [3]. These include
reduced linear growth, compromised endocrine and sen-
sory functions, and damage to cardiac and reproductive
systems.
In addition to the effects on children, adverse conse-
quences for parents' immediate and longer-term physical
and mental health have been reported [4-6]. Many par-
ents report elevated levels of depression and anxiety espe-
cially in the months immediately after diagnosis [7], but
for most this decreases over time [5,8,9].
Improvements in survival are the result of increasingly
aggressive treatments, raising questions about the quality
of life (QOL) as well as quantity or length of survival. For
the child, QOL is likely to be compromised by the pain of
illness and treatment, lack of energy to enjoy everyday
activities, and fears about the future. Mothers themselves
experience great changes to their lives, staying in hospital
with their child, perhaps giving up or reducing the hours
they spend at work, as well as learning how to manage the
child's medical care at home. The relatively recent emer-
gence of standardised QOL measures provides the oppor-
tunity to formalise the extent to which QOL is
compromised for mothers and children following diagno-
sis, and to describe any differences in impact depending
on characteristics of the child (age, gender) and illness.
In this study, we obtained ratings from mothers about
their own, and their child's QOL, and compared these
with population norms. We predicted that, in the months
immediately after diagnosis, mothers would rate their
own and their child's QOL significantly below norms for
the normal population. Second, we explored relation-
ships between mothers' QOL and more illness-specific
worries, and third, predicted that mothers who rated their
own QOL to be poor would also rate their child's QOL to
be poor.
Methods
Procedure
Families of a newly diagnosed child were invited to partic-
ipate in a study about coping with the child's illness. Fam-
ilies were approached approximately three months after
diagnosis, as the child's condition is normally relatively
stable, and treatment is on an out-patient basis. Families
were approached by the clinic nurse at a routine clinic visit
and given written and verbal information about the study.
Those who agreed to participate gave signed consent and
were subsequently contacted by the research team who
visited the family at home. All aspects of the procedure
were approved by the Hospital Ethics Committees.
Sample
English-speaking families of children aged 2–18 years
diagnosed at five cancer centres in the UK over a two-year
period were approached. Exclusions were children with
advanced disease, cognitive or neurological impairment
prior to diagnosis, or other complicating conditions (e.g.
Down's syndrome).
A total of 87 families took part (60%) of those eligible.
Families who refused cited lack of interest, too distressed
or too busy as explanations. The sample was predomi-
nantly Caucasian; there were two families of Asian origin,
but both had lived in the UK for more than 10 years. There
were 58 males and 29 females. The ages of the children
ranged from 2 years 6 months to 16 years 3 months
(mean = 7 years, median = 5 years 8 months). Children
were being treated for acute lymphoblastic leukaemia
(ALL, n = 57), brain tumours (n = 11), bone tumours (n =
17) and 2 rare cancers.
Questionnaires
Child's QOL
The Pediatric Quality of Life Inventory (PedsQL ™ 4.0)
[10] includes subscales to measure physical health, social,
school and emotional functioning. There are separate age-
appropriate versions including one for children aged 2.5–
4 years. For each item, mothers are asked how much of a
problem has been experienced over the last month. Items
are rated on 5-point Likert scales, from 0 (never a prob-
lem) to 4 (almost always a problem). After aggregation
and transformation, subscale scores range from 0–100,
with higher scores representing better QOL.
The Maternal worry scale [11] is an 11-item scale that
measures mothers' worries concerning the child's future.
Examples of the items include worries about future reli-
ance on medication, becoming worse in the future and
feeling different from others as a result of the illness. TheHealth and Quality of Life Outcomes 2005, 3:29 http://www.hqlo.com/content/3/1/29
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scale has shown adequate psychometric properties, an
internal consistency (Cronbach's α ) of 0.94 and a test-
retest reliability of 0.84.
Mothers' well-being
The SF-36 scale [12] was included as a measure of moth-
ers' own well-being. This includes a single-item measure
of change in health, plus eight subscales, with varying
numbers of items and response formats, defined as phys-
ical functioning, role limitation (physical), role limitation
(social), social functioning, mental health, energy/vitality,
pain and general health perception. The scale has been
extensively used in health services research, has estab-
lished psychometric properties and UK norms [13].
Medical data
Information about diagnosis and date of diagnosis were
obtained from medical records.
Treatment of results
There was considerable missing data for the school func-
tioning subscale of the PedsQL ™ 4.0, which mothers did
not complete whenever children were below school age or
had not yet returned to school after diagnosis. This sub-
scale was therefore excluded from analyses. We then cal-
culated reliabilities for all the remaining scales and
subscales. Internal consistency was consistently good (see
Table 1). Comparisons between sample means and popu-
lation means were based on 1 sample t-tests and relation-
ships between variables investigated suing simple
correlations. All analyses were conducted using SPSS
version 10 for Macintosh.
Results
Comparisons with population norms
Consistent with our first hypothesis, mothers reported sig-
nificantly lower QOL for their child compared with pop-
ulation norms (14). They also reported their own QOL to
be lower than expected across most subscales (13), nota-
ble exceptions being the SF-36 subscales relating to phys-
ical function and pain, where mothers reported
functioning within the normal range. These data are
shown in Table 1.
Relationship between mothers' own QOL and worries
Mothers who reported more worries rated their own (r = -
.53) and the child's QOL (Physical r = -.31; Emotional r =
-.36; Social r = -.42) to be lower.
Relationship between mothers' own QOL and their ratings 
of the child's QOL
There were significant correlations between mothers' rat-
ings of their own QOL and their ratings of the child's QOL
(Physical: r = 0.43; Emotional r = 0.43; and Social r =
0.52). Mothers' ratings of the child's QOL suggested no
differences depending on diagnosis, child age or gender.
Discussion
Our results suggest that, in the three to five months fol-
lowing diagnosis of ALL, mothers report that children's
QOL is significantly compromised compared with the
normal population. Although this is to be expected, the
extent to which QOL scores were below population
means was considerable. On most subscales of the SF-36,
mothers also reported their own QOL to be lower than
population means. Our results attest to the huge burden
experienced by children and their parents during the ini-
tial period of treatment for cancer.
Table 1: Child and parental QOL measures: means, norms and reliabilities
Measure (n) mean Norm alpha t
Child's QOL
Physical Functioning 74 36.6* 84.9 0.86 -20.2
Emotional Functioning 74 48.2* 74.7 0.75 -10.76
Social Functioning 74 66.4* 86.6 0.80 -7.63
Parent's QOL
Physical Function 66 91.77 89.5 0.91 1.19
Social Functioning 68 59.2* 86.9 0.82 -7.37
Role Limitation – Physical 69 67.0* 84.6 0.85 -3.82
Role Limitation – Emotional 66 47.0* 80.6 0.77 -6.48
Mental Health 69 54.5* 72.0 0.76 -7.16
Energy/Vitality 68 44.6* 58.6 0.80 -5.01
Pain 68 84.2 79.9 0.77 1.48
General Health Perception 68 73.0 75.0 0.85 -0.86
Worry 65 2.07 N/A 0.87
* Sample mean indicating significantly lower QOL than norm (p < .05, 1-tailed test).Health and Quality of Life Outcomes 2005, 3:29 http://www.hqlo.com/content/3/1/29
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Although correlations give no information about the
direction of a relationship (whether worries compromised
QOL or vice-vera), we found that mothers who were more
worried reported lower QOL themselves. Finally, moth-
ers' ratings of their own QOL were correlated with their
ratings of the child's QOL. Although it is normally recom-
mended that ratings of QOL should be made by the
patient wherever possible, it has always been acknowl-
edged that there are situations, especially where children
are very young or ill, when it is necessary to rely on par-
ents' ratings. Diagnosis of cancer in a child is likely to be
one of those situations, in so far as children are often
young, ill and distressed. Our data suggest that mothers
can provide ratings of the child's QOL but these are
related to their own QOL. Mothers who rated their own
QOL to be lower and reported more worries, rated the
child's QOL to be worse. There is a question about how
well mothers are able to report their child's QOL. A
number of reports suggest there are differences between
mothers and children in their views of the child's QOL,
although these have not been related in any simple way to
variables such as age or gender [15].
Study limitations include reliance on mothers' ratings of
their own and their child's QOL. Although we had wanted
to measure children's QOL by asking them directly, there
were a number of obstacles to achieving this. First, the
average age on diagnosis of ALL is 4 years, meaning that
many children were simply too young to respond for
themselves. Second, on diagnosis, even the older children
tended to be too ill to respond.
The reliance on mothers, rather than fathers, may also be
a limitation. Mothers tend to be more involved with the
care of the sick child, more responsible for medication
and treatment decisions, and more likely to stay in hospi-
tal with the child. In contrast, fathers tend to work as
much as possible and generally try to maintain normal
family life for other children in the family [16]. This dif-
ference in experience, resulting in fathers remaining more
involved in everyday life despite the child's illness, may
have an impact on parenting and parents' perceptions of
the child's QOL.
In addition, our sample included only 60% of those eligi-
ble. We have no way of knowing whether those who
refused differed in any crucial way from families who
agreed to take part, though typically they stated they were
too busy or distressed. Given the suddenness of the diag-
nosis and the amount of hospitalisation and care typically
needed, it is not surprising that some families were over-
whelmed and did not wish to add an additional demand
on their time. As Ethics committees do not allow investi-
gators to probe families reasons for agreeing or not to take
part in research, we are unable to be any more precise on
this point.
A further limitation follows from use of PedsQL ™ 4.0 as a
measure of QOL. The PedsQL ™ 4.0 was developed as a
generic measure of children's QOL, and therefore does
not tap specific implications associated with diagnosis
and treatment. Mothers failed to complete ratings in the
schools subscale, on the basis that many children were
attending sporadically or experienced very lengthy
absences. This suggests the measure may lack sensitivity
for newly diagnosed children and challenges the adequacy
of generic measures of QOL to provide a comprehensive
assessment of QOL in children with serious illness. Use of
cancer specific scales would be helpful [17], though cur-
rently lack UK norms.
It is important that work of this kind has clinical implica-
tions for parents and medical staff. There are concerns that
the treatments currently used to treat cancer may unneces-
sarily compromise child QOL, both during treatment and
in the longer term [18]. Although use of Hickman lines
and anti-emetic drugs are now routine and have reduced
children's experiences of pain and chemotherapy related
sickness, our data suggest much still needs to be done to
improve QOL in children on treatment. Fear of infection
and children's fatigue mean that families lead very iso-
lated lives after diagnosis. If QOL is to be further
improved, we need to find ways to reduce the sense of
loneliness and isolation experienced, as well as family
fears for the future.
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